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ABSTRACT 
This review evaluates the current understanding of research on the impact of physical 
activity in the prevention of colorectal cancer. Current biological mechanisms implicated 
in physical activity and colorectal cancer risk reduction are blood glucose regulation, 
insulin sensitivity, leptin and adiponectin profiles, inflammation as well as secreted 
protein acidic and rich in cysteine (SPARC), an exercise induced myokine. Recent 
literature indicates that 30-60 minutes of moderate to vigorous activity a day is effective 
against colorectal cancer development, and there is convincing evidence of aerobic 
exercise as differently beneficial in recruiting mechanisms identified as preventative 
against colorectal cancer. This article provides a critical review of the evidence-based 
literature concerning the benefits of physical activity in reducing the risk for colorectal 
cancer. Further well designed animal and clinical trials testing differing exercise 
protocols are recommended for future research to enable better understanding of the 
currently implicated mechanisms in colorectal cancer development.   
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CHAPTER 1 
INTRODUCTION 
According to the American Cancer Society’s 2013 statistics, colorectal cancer is 
the third most prevalent cancer among men and women in the United States. Despite 
mortality rates declining in the population over 50 years of age, rates of colorectal cancer 
incidence in individuals under 50 years of age are on the rise.  The etiology of colorectal 
cancer is a complex phenomenon that involves the interaction of genetic and 
environmental factors.  However, the vast majority of cases can be ascribed to 
environmental causes as they account for more than 80% of all incidences 
1
.  Physical 
inactivity has emerged as a leading environmental risk factor for colorectal cancer.  
According to the World Health Organization (WHO), physical inactivity is the fourth 
leading risk for mortality globally; it is responsible for 6% of all deaths worldwide.  In 
fact, physical inactivity raises the risk for numerous chronic diseases such as heart 
disease 
2-6
, diabetes 
7-11
 and various cancers including colorectal cancer 
12-17
.  Physical 
inactivity is thought to account for 13-14% of all colorectal cancer cases 
18
.   Thus, the 
American Cancer Society speculates that the increase in colorectal cancer incidence 
among the younger population is, at least in part, due to a sedentary lifestyle. Conversely, 
physical activity or exercise training has been linked to a reduced risk for colorectal 
cancer; epidemiological studies indicate an inverse association between physical activity 
and colorectal cancer risk and controlled experiments in mice substantiate these claims.   
While there is an abundance of data to support a link between physical activity and 
 2 
colorectal cancer risk, the mechanisms responsible for this relationship have not yet been 
fully elucidated.  
Possible mechanisms that link physical activity to reduced colorectal cancer risk 
have been investigated using epidemiological studies as well as controlled experimental 
studies in mice.  Mouse models that recreate the colorectal cancer development seen in 
humans have been particularly useful in examining the benefits of exercise on colorectal 
cancer risk in a controlled setting (i.e the dose of exercise can be controlled).  For 
example, the Apc
Min/+ 
mouse that develops intestinal colon polyps similar to an 
aggressive case of human colorectal cancer has been widely used in exercise studies. 
Also, carcinogens that induce colorectal cancer including azoxymethane, (AOM) and 1,2-
dimethyl hydrazine, (DMH) have been utilized to investigate the effects of exercise on 
colorectal cancer in both mice and rats.  To date, the mechanisms that have been 
implicated in the benefits of physical activity on colorectal cancer risk include insulin 
regulation, leptin and adiponectin profiles, inflammatory processes as well as secreted 
protein acidic and rich in cysteine (SPARC), an exercise induced myokine.  This review 
will examine the recent literature on the aforementioned mechanisms that are thought to 
link physical activity to reduced colorectal cancer risk. 
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CHAPTER 2 
METABOLIC MEDIATORS 
Metabolic mediators control growth and development, regulate energy output and 
storage, and work to maintain healthy body mass. Imbalances in their concentrations have 
been linked to a heightened risk for colorectal cancer.   
2.1 INSULIN 
Insulin is a hormone produced by beta cells in the pancreas; it functions to 
regulate blood glucose levels.  Evidence indicates that insulin resistance and its 
associated pathological conditions including elevated fasting glucose and insulin are 
implicated in  colorectal  cancer 
19
.  Risk factors for colorectal cancer,  including  obesity,  
physical inactivity and type 2 diabetes are all linked to insulin resistance and 
hyperinsulinemia 
20,21,22,23,24
.  While epidemiological evidence only indirectly associates 
insulin with colorectal cancer risk, strong evidence implicates insulin as player in 
colorectal cancer.  For example, insulin injections have been reported to enhance the 
growth of aberrant crypt foci as well as increase the number and size of colorectal 
tumors
2526
.  Similarly, in vivo evidence supports a tumor promoting role of insulin on 
colorectal cancer cells 
27,28,29,30
.  Alterations in insulin may play a role in the benefits of 
exercise on the development of colorectal cancer.  It is well recognized that exercise can 
decrease hyperinsulinemia.  For example, in a study of one hundred Type 2 diabetic 
obese or overweight subjects, exercise was successful at reducing plasma insulin levels. 
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Within this high-risk population, a significant decrease in plasma insulin levels across all 
exercise modalities was reported.  The greatest effect was seen in those subjects 
performing aerobic training in conjunction with resistance training 
31
.  To date, there is no 
direct evidence linking exercise to the prevention of colorectal cancer via a reduction in 
insulin levels.  However, lowering baseline serum levels of insulin through exercise 
would presumably attenuate insulin’s well-documented effects on colorectal cancer 
development. 
2.2 INSULIN GROWTH FACTOR 1 
Insulin-like growth factors (IGF-I and IGF-II) and their binding proteins (IGFBP-
1 and IGFBP-6) have been linked to colorectal cancer risk in epidemiological studies as 
well as controlled experimental studies in mice 
32,33
.  IGFs promote proliferation and 
survival of a wide range of cell types and are thus critical for normal development.  
However, dysregulation of the IGF system has been implicated in a range of diseases 
including colorectal cancer.  For example, epidemiological studies have shown that 
higher circulating IGF levels are associated with increased risk for colorectal cancer 
34
. 
This relationship is supported by controlled experimental studies in mice; colorectal 
cancer growth is decreased in mice following deletion of the IGF1 gene 
35
.  In vitro 
studies have documented that the IGF-1 receptor facilitates malignant transformation of a 
number of oncogenes 
36
.  And there is an abundance of literature to support the role of 
IGF-1 on promotion of survival, proliferation, migration and invasion of many cell types. 
For example, in vitro IGF-1 promotes cell cycle progression and inhibition of apoptosis 
in several colonic adenocarcinoma cell lines 
37, 29
.  
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Exercise training has been shown to influence IGF levels, which may be a 
potential mechanism for the benefits of exercise on colorectal cancer.  However, the 
dynamics of this relationship is likely heavily influenced by the intensity, mode and 
duration of the training regime.  Several studies suggest that initiation of a training 
program, which is associated with a substantial increase in energy expenditure, leads 
initially to decreases in IGF levels.  Conversely, following adaptation to the training the 
suppression of IGF is diminished and in fact IGF may exceed the pre-training levels.  
Therefore, the relationship between exercise and IGF is potentially very complex, which 
likely explains the inconsistent findings on its potential in the literature.  For example, 
one study reported that voluntary wheel running exercise was associated with a lower 
polyp number in Apc
min
 mice but the exercise group actually showed higher IGF-1 levels; 
although there was no association between polyp number and IGF reported 
38
. Contrary 
to those findings, recent literature has shown that IGF-1 levels are slightly lowered (~9%)       
a carcinogenic mouse model (AOM/DSS) of colorectal cancer following voluntary 
exercise 
39
. However, the decrease was only significantly correlated with the lower colon 
tumor formation in AOM/DSS-treated mice when the associated increasing IGFBP-3 
levels were considered 
39
.  Ju et al hypothesized a lower molar ratio of IGF-1 to IGFBP -
3 (IGF binding protein) was responsible for inhibiting tumor growth in these mice 
39
. 
Although studies in animal literature support a positive effect of exercise on IGF-1 in 
colorectal cancer, the evidence has been mixed, possibly due to the complex nature of 
IGF-1’s interactions with a number of other contributing factors as well as the diversity 
of exercise protocols used in these studies. More research detailing IGF-1’s responses to 
exercise are needed to formulate a better evidence base within the mouse model. To date, 
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there are no clinical studies on the effects of exercise on IGF-1 in colorectal cancer, this 
is likely due, at least in part, to the conflicting evidence foundation in the animal 
literature. 
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CHAPTER 3 
ADIPOKINES 
Adipose-derived hormones (adipokines), along with their customary role in 
energy homeostasis, have been identified as potential mediators of the effects of exercise 
on colorectal cancer risk.  
3.1 LEPTIN 
Leptin is a long-term regulator of energy expenditure and food intake.   Leptin has 
been shown to stimulate intestinal oncogenesis through a variety of signaling pathways
40
. 
The hypothesized link between leptin and colorectal cancer was driven initially by reports 
of leptin receptor expression by various human epithelial colon cancer cell lines. When 
bound to leptin, the receptor can activate signal transduction pathways that can enhance 
cell proliferation and DNA synthesis.   For example, Fenton et al., reported that leptin 
promotes the proliferation of preneoplastic (IMCE) cells 
41
.  While the in vitro evidence 
is relatively strong, there are mixed reports among the animal studies.  A recent study 
found a significant decrease of tumor cell proliferation in leptin-deficient tumors, as well 
as a dramatic inhibition of tumor growth in leptin-deficient and leptin-receptor-deficient 
mice 
42
.  Whereas a previous study reported that leptin failed to promote growth of colon 
cancer xenografts in nude mice and did not increase intestinal tumorigenesis in Apc
Min/+ 
mice 
43
.  Clinical investigations have reported that a progressive increase in leptin occurs 
during colorectal carcinogenesis 
44
.  Taken together, the available literature suggests that 
lowering baseline levels of leptin could lower risk for developing colorectal cancer.  It 
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has been shown that exercise can significantly reduce baseline leptin levels in APC 
Min 
mice 
45
.  However, it is important to note that while small changes were seen in male 
polyp development, no decrease in female mice tumor load was observed; therefore, the 
relevance of these findings are inconclusive.  Follow up studies by Colbert et al 
demonstrated that a greater frequency and duration of voluntary wheel running decreased 
male polyp count by 25%, but in those studies, energy balance, rather than leptin was the 
mechanism investigated 
38
.  Citing Colbert et al’s decision to conclude investigating 
leptin mechanistically after their first study, it can be presumed that although dated  
animal research found that exercise was effective in lowering baseline leptin levels, 
current research does not support a leptin mediated link between exercise and colorectal 
cancer prevention.  However, it is important to note that the observed decrease in leptin 
with exercise, independent of colorectal cancer, is likely due to the exercise-induced 
decrease in fat mass. 
3.2 ADIPONECTIN 
Adiponectin (APN) is an adipokine secreted exclusively by adipose tissue, which 
has been reported to be negatively associated with colorectal cancer risk; a decrease in 
adiponectin is associated with increased risk for colorectal cancer. Adiponectin’s 
suppressive role in tumorigenesis has been widely documented in mouse models of 
colorectal cancer 
46,47
.  More recent animal studies have used APN deficiency models to 
mechanistically determine its role in both the risk and development of colorectal cancer. 
For example, Saxena et al reported that APN deficiency was associated with higher 
expressions of pro-inflammatory and pro-cancerous markers 
48
.  Further, APN knockout 
mice showed greater tumor numbers as well as greater tumor area due to an increase in 
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colonic mucosal erosion that resulted from a thinning of the mucosal lining 
49
.  Another 
study examined the role of APN in a carcinogenic as well as a genetic mouse model of 
colorectal cancer.  It was found that deficiency of APN increased tumorigenesis in both 
models; in the Apc
min/+
 mouse model APN-/- increased tumorigenesis by 3.2 fold and in 
the carcinogenic model by ~70% 
50
. 
Several studies have examined the benefits of exercise on APN in the settings of 
colorectal cancer.  To date, Saxena et al has reported the most promising data to support 
the protective effects of exercise on colorectal cancer development.  They report 
increased serum levels of APN by exercise training and suggest that it may be one of the 
mechanisms for the protective role of exercise of inflammatory processes in a 
carcinogenic mouse model of colitis. 
51
.  As expected, their APN deficient mice were 
more susceptible to inflammation than their wild-type counterparts and the benefits of 
exercise on inflammation were lost in their APN deficient mice.  Other studies have 
demonstrated similar effects of exercise on APN levels.  Tang et al noted a particularly 
interesting shift of APN levels in rats in response to exercise.  High fat diet feedings for 8 
weeks decreased circulating APN levels; however, 8 weeks of exercise training reversed 
this effect 
52
. Such results prove promising for prompting additional studies to improve 
our understanding of the effects of exercise on adiponectin in the settings of colorectal 
cancer.  
As with the animal literature, higher levels of APN have been implicated in 
having a protective role in the development of human colorectal cancer.  For example, an 
inverse relationship between serum APN and colorectal cancer grade was observed in a 
recent case study involving subjects diagnosed with colorectal cancer 
53
. Further, the 
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benefits of exercise on APN have also been investigated, although not in the settings of 
colorectal cancer. To date, few clinical trials have investigated the specific effects of 
exercise on APN levels.  This is presumably due to the fact that the effect of exercise on 
circulating APN levels varies by individual; this may be attributed to variances in genes 
or environmental factors 
54
. A study by Lee et al sought to understand the activity of 
APN polymorphisms and completed a study on obese women having variations of two 
polymorphisms of the APN gene that are reported to be associated with insulin resistance 
and APN levels 
55
. They found that regardless of polymorphism, aerobic training over 3 
months increased circulating APN levels 
56
. Because studies in mouse models have 
reported that an increase in APN levels decreases polyp development and load, 
presumably these subjects would have attenuated risk for colorectal cancer given the 
exercise-induced increase in APN. In addition, these individuals had a significant 
decrease in body weight, BMI, and waist circumference, which would also mitigate their 
risk of developing colorectal cancer. Although the clinical literature available seems 
promising, further clinical studies are needed to confirm the link between exercise, 
adiponectin and the development of colorectal cancer outside the animal model. 
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CHAPTER 4 
INFLAMMATION 
The colon has evolutionarily outfit itself with a large population of 
immunologically active cells to defend the body against invasion and to regulate 
homeostasis 
57
. It is through their modulation that the release of inflammatory cytokines 
is regulated 
58
. If, over time, these cells are constantly expressing higher than normal 
levels of these inflammatory cytokines it can lead to chronic intestinal inflammation. It 
has been hypothesized not only that colorectal cancer pathogenesis may be influenced by 
the state of this chronic intestinal inflammation 
59
, but also that regular exercise is 
capable of mitigating it.   
4.1 TNF ALPHA 
TNF-α is a cytokine involved primarily with systemic inflammation. Its effector 
cells (immune cells) regulate the inflammatory response to a number of different assaults 
and through initiation of a variety of inflammatory cascades. TNF-α has been found to be 
a main stimulant of colitis-associated colorectal cancer 
59
. The most likely mechanism for 
this response is that TNF-α elevates the activity of inflammation-sensitive transcription 
factors such as NF-κB 60 as well as the inflammatory cytokines IL-6 and IL-1β 61.  We 
have shown that TNF-α mRNA expression is increased in the intestines of the ApcMin/+ 
mouse, which is associated with the abundance of large polyps 
62
.  Further, using a 
monocyte chemoattractant protein 1 (MCP-1) knockout mouse we have reported a 
decrease in the number of macrophages in the polyp tissue, which was linked to a 
 12 
reduction in TNF-α expression 63.  This is of particular importance given that the 
predominant expression of TNF-α in colorectal cancer is observed within tumor 
associated macrophages 
64
.  Direct evidence for the involvement of TNF-α in cancer 
comes from observations that antibodies against TNF-α inhibit the development of 
inflammation-related colon cancer 
65
.  
While the available literature on the benefits of exercise on TNF-α in colon cancer 
is limited, the studies that are presented are promising.  For example, recently it has been 
shown that regular exercise suppressed the generation of aberrant crypt foci in the colon 
following AOM and this was associated with decreased levels of TNF-α in both the colon 
and plasma 
66
.  Similarly, TNF-α expression in intestinal lymphocytes of younger 
C57BL/6 mice has been shown to be decreased with voluntary wheel running exercise 
suggesting that long term exercise may protect the bowl by reducing intestinal 
inflammation 
67
.  Further, a recent study in aged C57BL/6 mice demonstrated that regular 
exercise lowered TNF-α in plasma and serum 68.  Although good evidence for a benefit of 
exercise on TNF-α in colorectal cancer in animals is beginning to accumulate in the 
literature, the clinical data is disappointingly sparse and relatively undocumented. None-
the-less a team in India has demonstrated that humans respond accordingly to regular 
exercise, with over 70% of subjects lowering their baseline values of TNF-alpha after one 
month of moderate exercise 
69
. 
4.2 IL 6 
Interleukin-6 or (IL)-6 is a pleiotropic cytokine that modulates a variety of 
physiological responses and activates genes associated with cellular proliferation, 
differentiation, and apoptosis.  Epidemiological studies indicate an association between 
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IL-6 and colorectal cancer and controlled experiments in mice substantiate these claims.  
This effect is thought to be largely mediated through its ability to increase intestinal 
inflammation 
70
.   A recent study reported that IL-6 expression in stage III colon cancer 
patients is a prognostic marker of tumor behavior 
71
.  Further, using IL-6 knockout mice 
as well as IL-6 overexpression techniques, Baltgalvis et al., eloquently examined the role 
of IL-6 on tumor characteristics in the Apc
Min/+
 mouse model of colon cancer.  They 
reported that knocking out IL-6 reduced the number of large polyps by approximately 
30% and these effects were reversed when IL-6 was overexpressed 
72
.  Interestingly, they 
also demonstrate that IL-6 is necessary for the onset of adipose and skeletal muscle 
wasting in the Apc
Min/+
 mouse as IL-6
-/-
 mice did not lose gastrocnemius muscle mass or 
epididymal fat pad mass while IL-6 overexpression led to a decrease in mass for each of 
these tissues. 
IL-6 has been implicated in the link between exercise and colorectal cancer; 
several studies have reported a benefit of exercise on IL-6 in colorectal cancer.  One 
study reported that nine weeks of moderate treadmill running decreased total intestinal 
polyps by 29% in male  Apc
Min/+
 mouse and this was associated with a 98% decrease in 
IL-6 
73
.  A follow up study by the same group documented that moderate-intensity 
treadmill exercise can attenuate IL-6-dependent cachexia in Apc
Min/+
 mice, independent 
of changes in IL-6 concentration and muscle inflammatory signaling 
74
.  The exercise 
effect was associated with improved insulin sensitivity and improved energy status in the 
muscle. Similarly, IL-6 induced mitochondrial remodeling and proteolysis was 
documented to be rescued with moderate exercise training even in the presence of high 
circulating IL-6 levels 
75
.  While there is good evidence to support an effect of exercise 
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on IL-6 in mouse models of colorectal cancer, there is very little clinical evidence in this 
area.  Although given the well documented effects of moderate exercise training on 
reducing IL-6, it is likely that these same outcomes will be seen in the human literature. 
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CHAPTER 5 
SPARC 
It has been postulated that the exercise-induced production of novel myokines can 
alter the mechanisms involved in colorectal cancer pathogenesis.  In a recent study, Aoi 
et al. suggested that the anti-tumor effect of regular exercise was more dependent on 
circulating factors rather than endogenous proteins in the colon 
66
.  One such myokine, 
secreted protein acidic and rich in cysteine (SPARC) also known as osteonectin, is a 
matricellular protein that is involved in cell to cell interaction, growth factor function and 
cell differentiation 
76
.  A recent study by Aoi et al examined the effects of exercise on the 
expression of this novel myokine in the muscle of mice and humans following a single 
bout of exercise.  It was found that a single bout of aerobic exercise increased plasma 
levels of SPARC in both humans and mice via promotion of SPARC upregulation in 
contracting myocytes 
77
.  Although SPARC returned to baseline levels after 6 hours in 
humans, their studies demonstrate that regular exercise enhanced the secretory ability of 
SPARC in response to muscle contraction by increasing the amount of SPARC in resting 
muscle tissue 
77
.  Using SPARC knockout mice, they went on to examine if the benefits 
of exercise on colorectal cancer may be mediated by SPARC.  They found that low-
intensity exercise reduced aberrant crypt foci growth in a chemically-induced mouse 
model of colorectal cancer.  However, the benefits of exercise were lost in SPARC 
deficient mice implicating a role of SPARC on the benefits of exercise in colorectal 
cancer. Further, exercise enhanced apoptosis in colon mucosal cells but again these 
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effects were not evident in SPARC deficient mice.  These recent findings concerning up-
regulation of SPARC via aerobic exercise provide yet another outlet to investigate the 
promising effects of exercise in prevention of colorectal cancer.  Further studies are 
needed to better elucidate SPARC’s effects on the known mechanisms of colorectal 
pathogenesis. 
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CHAPTER 6 
PHYSICAL ACTIVITY AND EXERCISE RECOMMENDATIONS 
Physical activity (PA) is defined by the American College of Sports Medicine as 
any bodily movement created from muscle contraction and resulting in an energy 
expenditure increase over that of resting energy expenditure (REE).  Exercise is a 
planned and structured form of PA that uses repetitive bodily movement to improve or 
maintain one or more components of physical fitness, which are simply characteristics 
that allow one to perform physical activities.  
The World Health Organization’s Global Recommendations on Physical Activity 
for Health (2008) focus mainly on type, duration, frequency, intensity, and volume of 
physical activity.  These recommendations are minimum guidelines allotted to provide 
benefits in cardiorespiratory health, metabolic health, bone health, depression and breast 
and colon cancer.  WHO recommends at least 150 minutes of moderate intensity aerobic 
physical activity or at least 75 minutes of vigorous physical activity per week. WHO’s 
guidelines also note that at least 30-60 minutes per day of moderate to vigorous activity is 
needed to observe significantly lower risks of breast and colon  cancer 
78
.  
While epidemiological data suggested higher durations of physical activity is 
protective against colorectal cancer, the early animal literature was inconclusive.  Colbert 
et al noted that while prior epidemiological studies and studies in chemically induced 
cancerous rats concluded a beneficial influence of exercise on tumor polyp load, their 
2002 work provided limited evidence for possible preventative effects against intestinal 
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tumorigenesis in male Apc
min/+ 
mice, and no evidence for an effect in female 
Apc
min/+ 
mice 
45
.  Subsequently, advances in exercise protocols as well as additional 
investigation into pivotal mechanisms surrounding the development of colorectal cancer 
have established a dose-response relationship supporting the suppressive nature of 
exercise on colorectal cancer.   
Recent studies by Colbert et al with C57BL/6J-Apc
Min
 mice reported that 
voluntary treadmill running and the negative energy balance resulting from pair-feeding 
with a non-exercising control group decreased polyp number in a dose dependent manner 
in the running group.  The running group also maintained a significantly smaller overall 
body weight than the control group 
38
.  Similarly, another study reported that forced low-
intensity running and forced swimming reduced aberrant crypt foci, precursors to colonic 
adenocarcinomas, sustained from carcinogenic DMH-injections in rats 
79,80
.  More 
recently, in mice subjected to azoxymethane (AOM) injections, a tri-weekly running 
schedule for six weeks decreased aberrant crypt foci development compared to a 
sedentary treatment 
66
.  
While there is ample evidence to support a lower incidence of colorectal cancer 
development in animal models with higher levels of aerobic exercise, the clinical data 
supporting such a link is scarce by comparison.  However, McTiernan et al, found a 12-
month exercise intervention of 60 minutes per day 6 days a week decreased colonic crypt 
cell proliferation in healthy human subjects 
81
.  Because an increased cell proliferation 
rate and an extension of the normal proliferative zone within the colon crypt are 
reversible precursors of colonic neoplasia 
82
, these subjects, having lowered their 
proliferation rates, would have attenuated their risk for developing colorectal cancer. 
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Likewise, a 2011 meta-analysis of 20 clinical studies of physical activity and colonic 
polyps by Wolin et al concluded a significant inverse relation between physical activity 
and colon adenomas or polyps.  Wolin et al conclude that physical activity may reduce 
the risk of colon polyp development by 15%.  The reduction of risk by physical activity 
may also be substantially greater for large and advanced polyps 
83
.  Recent cohort studies 
also mirror animal and clinical findings on the positive role of physical activity on colon 
cancer risk.  A 2012 screening study of 912 multi-ethnic persons scheduled for an exam 
concluded that more than 60 minutes of exercise a week, was correlated with a low or no 
polyp count.  Subjects who performed at least 60 minutes of exercise weekly were less 
likely to have any detectable polyps compared to those who did not regularly exercise. 
They were also less likely to have an adenoma on their colonoscopy compared to their 
counterparts with more sedentary lifestyles 
84
.  The questions in the study pertaining to 
exercise were asked in a manner that inferred activity outside daily activity, i.e. exercise. 
Unfortunately, mode of exercise was not investigated in this study. 
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CHAPTER 7 
CONCLUSION 
The current body of evidence supports a positive effect of exercise, and in 
particular vigorous aerobic activity, on the prevention of colorectal cancer.  Animal 
studies support the hypothesis that exercise mediates this protective effect by inducing 
changes in blood glucose regulation, insulin sensitivity, the adiponectin profile, 
inflammation regulation and SPARC secretion.  For a better understanding of these 
mechanisms and their role in preventing tumorigenesis, further studies containing even 
more exercise protocol variations should be completed.  Granted the scarcity of current 
clinical data, future clinical studies are needed to support the conclusions of these animal 
studies.  Further advancements within this field are important for public health prevention 
practices and awareness that may aid in nudging the population towards healthier lifestyle 
choices. 
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